GRAIL (GRAL) Current Ratio: 11.74 (As of Mar. 2026) — 21% Above Median


GRAL GRAIL Inc GRAL
12 GF Score
Price $65.58
! 2 Warning Signs
View Full Analysis

What is GRAIL Current Ratio?

GRAIL GRAL -1.49% 12 Current Ratio is 11.74 as of Mar. 2026, which is 21% above its 10-year median of 9.68. GuruFocus rates GRAL with a GF Score™ of 12/100. The stock has 2 warning signs investors should review. Among 215 Medical Diagnostics & Research companies, GRAIL ranks better than 95.35% on this metric.

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. GRAIL's current ratio for the quarter that ended in Mar. 2026 was 11.74.

GRAIL has a current ratio of 11.74. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.

The historical rank and industry rank for GRAIL's Current Ratio or its related term are showing as below:

GRAL' s Current Ratio Range Over the Past 10 Years
Min: 0.95   Med: 9.68   Max: 15.68
Current: 11.74

During the past 6 years, GRAIL's highest Current Ratio was 15.68. The lowest was 0.95. And the median was 9.68.

GRAL's Current Ratio is ranked better than
95.35% of 215 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.96 vs GRAL: 11.74

GRAIL  (NAS:GRAL) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


GRAIL Current Ratio Related Terms


GRAIL Current Ratio Historical Data

* Premium members only.

The historical data trend for GRAIL's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GRAIL Current Ratio Chart

GRAIL Annual Data
Trend Dec18 Dec19 Dec22 Dec23 Dec24 Dec25
Current Ratio
Get a 7-Day Free Trial 12.41 2.19 0.95 10.66 11.97

GRAIL Quarterly Data
Dec18 Dec19 Jun20 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.71 9.23 7.61 11.97 11.74

GRAL vs VCYT, ADPT, TWST: Current Ratio Comparison

For the Diagnostics & Research subindustry, GRAIL's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GRAIL Current Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, GRAIL's Current Ratio distribution charts can be found below:

* The bar in red indicates where GRAIL's Current Ratio falls into.


GRAL
12GF Score
GRAIL Inc GRAL
Current Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GRAIL Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

GRAIL's Current Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Current Ratio (A: Dec. 2025 )=Total Current Assets (A: Dec. 2025 )/Total Current Liabilities (A: Dec. 2025 )
=953.849/79.67
=11.97

GRAIL's Current Ratio for the quarter that ended in Mar. 2026 is calculated as

Current Ratio (Q: Mar. 2026 )=Total Current Assets (Q: Mar. 2026 )/Total Current Liabilities (Q: Mar. 2026 )
=877.347/74.709
=11.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Current Ratio →
What does a Current Ratio of 11.74 mean?
GRAIL (GRAL) has a Current Ratio of 11.74 as of Mar. 2026. This is 21% above median its historical median of 9.68. Over the past decade, GRAIL's Current Ratio has ranged from 0.95 to 15.68. According to the industry distribution chart, GRAIL ranks #10 out of 215 companies in the Medical Diagnostics & Research industry, placing it in the top 4.7%.
Is GRAIL's Current Ratio too high?
GRAIL's current Current Ratio of 11.74 is 21% above median its 10-year median of 9.68. Over the past 10 years, this metric has ranged from a low of 0.95 to a high of 15.68. The Medical Diagnostics & Research industry median Current Ratio is 1.96. GRAIL's value of 11.74 is 499% above this industry median. Based on the distribution chart, GRAIL ranks #10 out of 215 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, GRAIL has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does GRAIL's Current Ratio compare to VCYT and ADPT?
According to the Medical Diagnostics & Research industry distribution chart, GRAIL ranks #10 out of 215 companies for Current Ratio. This places GRAIL in the top 5% of its industry — outperforming the majority of peers. The industry median Current Ratio is 1.96. GRAIL's value of 11.74 is 499% above this benchmark. Historically, GRAIL's own Current Ratio has ranged from 0.95 to 15.68 over the past decade. While the company's 10-year median is 9.68 vs. the industry median of 1.96, GRAIL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Diagnostics & Research company?
The median Current Ratio among Medical Diagnostics & Research companies is 1.96, based on 215 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GRAIL's current Current Ratio of 11.74 is 499% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Diagnostics & Research industry, the median Current Ratio is 1.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GRAIL's current Current Ratio is 11.74, which is 21% above median its own 10-year median of 9.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GRAIL stock overvalued right now?
GRAIL (GRAL) has a current Current Ratio of 11.74. The current Current Ratio is 11.74, which is 21% above median its 10-year median of 9.68 and 499% above the Medical Diagnostics & Research industry median of 1.96. GRAIL's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For GRAIL (GRAL), the current Current Ratio is 11.74 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GRAIL Business Description

Other Exchanges NL0:Germany
Address 1525 O’Brien Drive, Menlo Park, CA, USA, 94025
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
12GF Score

Get the complete analysis for GRAL

Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$65.58
Price